Four Accused By UK's CMA On Nortriptyline

King Pharmaceuticals and Auden Mckenzie have been accused by the UK’s competition regulator of sharing out the supply of nortriptyline 10mg and 25mg tablets, in a case that also implicates Alissa and Lexon for exchanging commercially-sensitive information as part of an effort to drive up prices.